AGE-Induced Suppression of EZH2 Mediates Injury of Podocytes by Reducing H3K27me3

Abstract

Background: Chronic hyperglycemia, a pivotal feature of diabetes mellitus (DM), initiates the formation of advanced glycation end products (AGEs) and the dysregulation of epigenetic mechanisms, which may cause injury to renal podocytes, a central feature of diabetic kidney disease (DKD). Previous data of our group showed that AGEs significantly reduce the expression of NIPP1 (nuclear inhibitor of protein phosphatase 1) in podocytes in vitro as well as in human and murine DKD. NIPP1 was shown by others to interact with enhancer of zeste homolog 2 (EZH2), which catalyzes the repressive methylation of H3K27me3 on histone 3. Therefore, we hypothesized that AGEs can directly induce epigenetic changes in podocytes. Methods: We analyzed the relevance of AGEs on EZH2 expression and activity in a murine podocyte cell line. Cells were treated with 5 mg/mL glycated BSA for 24 h. To determine the meaning of EZH2 suppression, EZH2 activity was inhibited by incubating the cells with the pharmacological methyltransferase inhibitor 3-deazaneplanocin A; EZH2 expression was repressed with siRNA. mRNA expression was analyzed with real-time PCR, and protein expression with Western blot. EZH2 expression and level of H3K27 trimethylation in podocytes of diabetic db/db mice, a mouse model for type 2 DM, were analyzed using immunofluorescence. Results: Our data demonstrated that AGEs decrease EZH2 expression in podocytes and consequently reduce H3K27me3. This suppression of EZH2 mimicked the AGE effects and caused an upregulated expression of pathological factors that contribute to podocyte injury in DKD. In addition, analyses of db/db mice showed significantly reduced H3K27me3 and EZH2 expression in podocytes. Moreover, the suppression of NIPP1 and EZH2 showed similar effects regarding podocyte injury. Conclusions: Our studies provide a novel pathway how AGEs contribute to podocyte injury and the formation of the so-called metabolic memory in DKD.

Association of podocyte injury with clinical features and prognosis in patients with mesangial proliferative lupus nephritis

“…Recent studies have suggested that renal aging may be one of the reasons for the tendency of elderly patients to suffer podocyte injury. 20,21 Further studies are required to determine whether kidney aging is associated with podocyte injury in Class II LN. Thrombocytopenia in SLE is typically caused by autoantibodies against platelet membrane and hyper-reactivity of B cells.…”

Identification of novel key molecular signatures in the pathogenesis of experimental diabetic retinopathy

“…Although alterations in H3K27 methylation have been reported in diabetic nephropathy, 67,68 they are scarce in the diabetic retina. In 2021, Duraisamy et al found that the levels of the H3K27 histone methyltransferase Ezh2 were increased at the MMP-9 promoter in diabetes, resulting in transcriptional activation of MMP-9.…”

Histone Lysine Methylation Modification and Its Role in Vascular Calcification

“…RAGE induces the conversion of VSMCs to osteoblasts through activation of signalling pathways such as ERK ( 163 ), NF-κB ( 164 ) and Wnt ( 160 ); thus, participating in VC. AGEs decrease EZH2 expression in podocytes and, consequently, reduces H3K27me3, causing an upregulated expression of pathological factors and contributing to podocyte injury in diabetic kidney disease ( 165 ). EZH2 is required in Wilm’s tumour 1 (WT1)-mediated β-catenin inactivation via repression of secreted frizzled-related protein 1 (SFRP-1), which is a Wnt antagonist, and EZH2-mediated silencing of SFRP-1 is due to increased H3K27me3 at its promoter area(s) ( 166 ).…”